...
首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Examining life-course influences on chronic disease: the importance of birth cohort studies from low- and middle- income countries. An overview
【24h】

Examining life-course influences on chronic disease: the importance of birth cohort studies from low- and middle- income countries. An overview

机译:检查生命过程对慢性病的影响:来自中低收入国家的出生队列研究的重要性。概述

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The objectives of this overview are to describe the past and potential contributions of birth cohorts to understanding chronic disease aetiology; advance a justification for the maintenance of birth cohorts from low- and middle-income countries (LMIC); provide an audit of birth cohorts from LMIC; and, finally, offer possible future directions for this sphere of research. While the contribution of birth cohorts from affluent societies to understanding disease aetiology has been considerable, we describe several reasons to anticipate why the results from such studies might not be directly applied to LMIC. More than any other developing country, Brazil has a tradition of establishing, maintaining and exploiting birth cohort studies. The clear need for a broader geographical representation may be precipitated by a greater collaboration worldwide in the sharing of ideas, fieldwork experience, and cross-country cohort data comparisons in order to carry out the best science in the most efficient manner. This requires the involvement of a central overseeing body - such as the World Health Organization - that has the respect of all countries and the capacity to develop strategic plans for `global' life-course epidemiology while addressing such issues as data-sharing. For rapid progress to be made, however, there must be minimal bureaucratic entanglements.
机译:本概述的目的是描述出生队列对了解慢性病病因的过去和潜在贡献;提出维持中低收入国家(LMIC)出生队列的理由;提供LMIC的出生队列审核;最后,为该研究领域提供可能的未来方向。尽管富裕社会的出生队列对理解疾病病因学的贡献是巨大的,但我们描述了一些原因,以期预测为什么这些研究的结果可能不会直接应用于LMIC。巴西比其他任何发展中国家都拥有建立,维护和利用出生队列研究的传统。全球范围内在共享思想,实地工作经验和跨国队列数据比较方面的更大合作可能会引发对更广泛的地域代表性的明确需求,以便以最有效的方式实施最好的科学。这就需要一个中央监督机构(如世界卫生组织)的参与,该机构应得到所有国家的尊重,并有能力制定“全球”生命历程流行病学战略计划,同时还要解决数据共享等问题。但是,要取得迅速的进展,必须有最小的官僚纠缠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号